乳腺癌细胞利用T3通过细胞Ca2+调制触发增殖
Ines Tawfik1, Katharina Schlick2, Julian Ostaku1
1Division of Molecular Biology and Biochemistry, Medical University of Graz, Neue Stiftingtalstraße 6/IV, Graz, 8010, Austria.
Cell communication and signaling : CCS
|November 7, 2024
概括
甲状腺激素三甲状腺激素 (T3) 通过增加线粒体摄取量和ATP产生来促进乳腺癌细胞的增殖. 这种T3驱动的途径支持癌症活力,但不是正常细胞的活力,提供了潜在的治疗标.
科学领域:
- 内分泌学 在内分泌学.
- 癌症生物学 癌症生物学
- 细胞代谢 细胞代谢
背景情况:
- 甲状腺激素水平升高与乳腺癌风险增加和进展相关.
- 三铁氨酸 (T3) 通过调节处理蛋白来增强癌细胞中线粒体ATP的产生.
研究的目的:
- 调查T3是否激活一种由诱导的信号通路,促进乳腺癌细胞增殖.
- 探索T3对各种癌症和非癌症细胞类型的差异性影响.
主要方法:
- 活细胞成像成像技术
- 生物化学测定 生物化学测定
- 分子造型分析 (MOP) 是一种分子造型分析.
- 在MCF7,MDA-MB-468,hTERT-HME1和PC3细胞系中进行比较分析.
主要成果:
- T3通过甲状腺激素受体α升调1,4,5-三酸盐受体3.
- 这导致线粒体摄取量增加和ATP产生,增强乳腺癌细胞活力和增殖.
- T3没有影响非癌性乳腺细胞 (hTERT-HME1) 或前列腺癌细胞 (PC3) 的增殖.
结论:
- T3通过特定的信号通路作为乳腺癌细胞代谢和增殖的关键调节者.
- 准T3通路可以通过利用癌细胞特定的脆弱性,为乳腺癌提供新的治疗策略.
相关概念视频
mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
Calmodulin-dependent Signaling
5.1K
Calmodulin (CaM) is a calcium-binding protein in eukaryotes that controls various calcium-regulated cellular processes. It has four calcium-binding sites that bind calcium to form the calcium-calmodulin ( Ca2+-CaM) complex. GPCR stimulation increases the calcium levels in the cells that bind to CaM and induces a conformational change.
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
5.1K
Cancer
48.1K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
48.1K
Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K
Mitogens and the Cell Cycle
6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K


